EPS of $17.32 (GAAP) earnings beat estimates of $10.59. Revenue of $3.18B beat estimates by 1.2%. EBITDA of $817M missed estimates by 2%. Revenue rose 20%. Organic growth was good at 6%, though f/x adjustments reduced this to 2%. Net income more than doubled year over year. Nearly $700M in acquisitions were done in the quarter, and another $627M post-quarter. Cash flow rose 9%. As usual the company did not provide a lot of data. But 6% (pre foreign exchange) is solid for organic growth, and may relieve some of the negative sentiment. It is good to see acquisitions at the pace they are at, implying CSU is continuing with its long term strategy that has been so successful. We are not sure this quarter will change sentiment dramatically, but we would consider these good results.EPS of $17.32 (GAAP) earnings beat estimates of $10.59. Revenue of $3.18B beat estimates by 1.2%. EBITDA of $817M missed estimates by 2%. Revenue rose 20%. Organic growth was good at 6%, though f/x adjustments reduced this to 2%. Net income more than doubled year over year. Nearly $700M in acquisitions were done in the quarter, and another $627M post-quarter. Cash flow rose 9%. As usual the company did not provide a lot of data. But 6% (pre foreign exchange) is solid for organic growth, and may relieve some of the negative sentiment. It is good to see acquisitions at the pace they are at, implying CSU is continuing with its long term strategy that has been so successful. We are not sure this quarter will change sentiment dramatically, but we would consider these good results.
5i Research Answer: